Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

BioInvent (Sweden) | Researchclopedia

Back to institutions

BioInvent (Sweden)

Lundcompany

172

Works

17,015

Citations

69

h-index

Top Research Topics

Monoclonal and Polyclonal Antibodies Research Glycosylation and Glycoproteins Research T-cell and B-cell Immunology

Top Researchers

Jan Nilsson University of Inland Norway

533 works21,606 citationsh-index: 76

Recent Research

Leveraging TNFR2 for antitumour immunity: T reg depletion and myeloid reprogramming versus T cell costimulation

Linda Mårtensson,Petra Holmkvist,et al.

20261 citations

Immune Cell Function and Interaction

Immunotherapy and Immune Responses

Chronic Lymphocytic Leukemia Research

HER2/EGFR in Cancer Research

Protein purification and stability

CAR-T cell therapy research

Advanced Biosensing Techniques and Applications

Atherosclerosis and Cardiovascular Diseases

Cancer Immunotherapy and Biomarkers

Mark S. Cragg Clarkson University

398 works21,031 citationsh-index: 67

Sapna P. Patel Maharaja Sayajirao University of Baroda

441 works20,816 citationsh-index: 51

Mats Nilsson Linköping University

457 works17,119 citationsh-index: 63

Lennart Truedsson Lund University

250 works12,423 citationsh-index: 57

Carl Borrebaeck Lund University

760 works11,923 citationsh-index: 60

Novel MTBR‐specific immunoassays MTBR‐1 and MTBR‐pTau262 for assessment of tau pathology in Alzheimer's disease

Fernando González‐Ortiz,Michael K Turton,et al.

20250 citations

Deletion or Targeted Blockade of FcγRIIb (CD32b) Impairs α-Syn Propagation <i>In-Vivo</i>

James Hennegan,Marja M. Hurley,et al.

20250 citations

Promising efficacy of BI-1206, an antibody targeting FcγRIIB in combination with rituximab and acalabrutinib in R/R NHL patients NHL

Laura Fogliatto,Filipa Cordeiro,et al.

20250 citations

BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter, showing promising efficacy in T cell lymphoma patients

Stefan K. Barta,Christiane Querfeld,et al.

20251 citations

581 Preliminary phase 1 results of clinical trial investigating BI-1910, a tumor necrosis factor receptor 2 (TNFR2) agonist, in solid tumor cancer patients

Tatiana Hernández‐Guerrero,Bernard Doger,et al.

20251 citations